Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Emmaus Life Sciences, Inc. | emma-ex321_6.htm |
| EX-31.2 - EX-31.2 - Emmaus Life Sciences, Inc. | emma-ex312_12.htm |
| EX-31.1 - EX-31.1 - Emmaus Life Sciences, Inc. | emma-ex311_21.htm |
| EX-10.38 - EX-10.38 - Emmaus Life Sciences, Inc. | emma-ex1038_544.htm |
| EX-10.37 - EX-10.37 - Emmaus Life Sciences, Inc. | emma-ex1037_13.htm |
| EX-4.27 - EX-4.27 - Emmaus Life Sciences, Inc. | emma-ex427_338.htm |
| EX-4.25 - EX-4.25 - Emmaus Life Sciences, Inc. | emma-ex425_284.htm |
| EX-4.24 - EX-4.24 - Emmaus Life Sciences, Inc. | emma-ex424_543.htm |
| 10-K - 10-K - Emmaus Life Sciences, Inc. | emma-10k_20201231.htm |
Exhibit 23.1
CONSENT OF BAKER TILLY US, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement No. 333-2225100 on Form S-3 and in the Registration Statements Nos. 333-150398, 333-215434, 333-225050, 333-228835 and 333-233718 on Form S-8, of Emmaus Life Sciences, Inc. of our report dated May 3, 2021, relating to the consolidated financial statements of Emmaus Life Sciences, Inc. appearing in this report on Form 10-K of Emmaus Life Sciences, Inc. as of December 31, 2020 and 2019 and for the years then ended.
/s/ BAKER TILLY US, LLP
San Diego, CA
May 3, 2021